TrialDrugs & aging2025

A Post Hoc Analysis of Older Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Plus Bevacizumab: The Randomized Obelics Study.

Gerardo Rosati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.